[1]
“Review of Next-Generation Non-Dopaminergic Antipsychotic Agents Targeting Central Muscarinic Receptors: Review Article”, JOPIR, vol. 4, no. 4, pp. 201–216, Aug. 2026, doi: 10.69613/fep10t11.